- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase IIa, Randomized, Parallel, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Enpatoran in Dermatomyositis and Polymyositis Participants receiving Standard of Care
This study is testing a new drug, Enpatoran, for dermatomyositis and polymyositis. Researchers want to see if it's safe and helps improve symptoms when added to usual care.
For: Dermatomyositis · PolymyositisItaly · Poland · Czechia - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus and in Cutaneous Lupus Erythematosus (Subacute Cutaneous Lupus Erythematosus and/or Discoid Lupus Erythematosus) Participants Receiving Standard of Care
This study is testing a new medicine called Enpatoran for people with lupus that affects their whole body or their skin. Researchers want to see if it's safe and helps improve symptoms compared to a dummy drug, and find the best dose.
For: Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE)Spain · Greece · Romania